155
Views
0
CrossRef citations to date
0
Altmetric
Commentary

The optimal chemotherapy regimen for primary mediastinal B-cell lymphoma: we may never know

Pages 1110-1111 | Received 23 Sep 2018, Accepted 30 Sep 2018, Published online: 08 Feb 2019
 

Potential conflict of interest

Disclosure form provided by the author is available with the full text of this article online at https://doi.org/10.1080/10428194.2018.1535119.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.